[wikichart align=”center” ticker=”PCBC” showannotations=”true” livequote=”true” rollingdate=”6 months” width=”390″ height=”245″] Pacific Capital Bancorp, the largest bank based in the region, earned $70.5 million in 2011, its first full calendar year under the ownership of a Texas-based private equity group. The parent company of Santa Barbara Bank & Trust saw its fourth-quarter profits drop 39.8 percent to Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks-based energy crop developer Ceres has plans to make its debut on the Nasdaq on Feb. 8 under the symbol CERE and raise $132 million. Shares in the company, which uses genetic marking technology to speed the development of non-food energy crops such as drought-resistant switchgrass, are expected hit the markets at between $21 Read More →
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Biotech giant Amgen, which said earlier on Thursday that it would pay $1.2 billion for leukemia drugmaker Micromet, reported fourth-quarter earnings that missed analyst expectations. The Thousand Oaks-based company said fourth-quarter profits fell 8.5 percent to $934 million, or $1.08 per share, on lower sales of Read More →
[wikichart align=”right” ticker=”NASDAQ:FCAL” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Westlake Village-based First California Financial Group reported profits of $23.4 million in 2011, a company earnings record. A year earlier, it had earned $1.4 million. “Our record breaking performance in 2011 was driven by the combination of continued successful execution of our strategic plan that focuses Read More →
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Thousand Oaks-based Amgen is buying a leukemia drug maker for $1.2 billion in a bid to boost its blockbuster drug lineup. Amgen, the world’s largest biotech company, said Jan. 26 that it will purchase Maryland-based Micromet, maker of an experimental leukemia drug. Investors of Microment will Read More →